ACUR
Acura Pharmaceuticals
ACUR
ACUR
Delisted
ACUR was delisted on the 22nd of February, 2017.
33 hedge funds and large institutions have $19.4M invested in Acura Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
12% less capital invested
Capital invested by funds: $22M → $19.4M (-$2.53M)
33% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 12
Holders
33
Holding in Top 10
1
Calls
$48K
Puts
$34K
Top Buyers
| 1 | +$92K | |
| 2 | +$63.9K | |
| 3 | +$59.2K | |
| 4 |
U
UBS
Zurich,
Switzerland
|
+$36.5K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$36K |
Top Sellers
| 1 | -$41.7K | |
| 2 | -$31.7K | |
| 3 | -$25.2K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$23K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$22.5K |